MERRIMACK PHARMACEUTICALS IN's ticker is and the CUSIP is 590328AA8. A total of 16 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q4 2014. The put-call ratio across all filers is - and the average weighting 1.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $5,606,000 | +385.8% | 4,500,000 | +350.0% | 1.06% | +303.4% |
| Q2 2016 | $1,154,000 | -95.6% | 1,000,000 | -94.2% | 0.26% | -96.8% |
| Q1 2016 | $26,125,000 | +0.7% | 17,250,000 | +4.6% | 8.28% | -33.7% |
| Q3 2015 | $25,947,000 | -25.9% | 16,490,000 | 0.0% | 12.49% | -3.7% |
| Q2 2015 | $35,012,000 | +0.1% | 16,490,000 | -5.1% | 12.97% | +19.4% |
| Q1 2015 | $34,992,000 | +22.6% | 17,370,000 | +16.8% | 10.86% | -3.5% |
| Q4 2014 | $28,544,000 | +105.7% | 14,870,000 | +67.6% | 11.26% | +137.2% |
| Q3 2014 | $13,877,000 | +46.0% | 8,870,000 | +26.7% | 4.75% | +77.5% |
| Q2 2014 | $9,508,000 | +515.0% | 7,000,000 | +366.7% | 2.68% | +213.6% |
| Q1 2014 | $1,546,000 | – | 1,500,000 | – | 0.85% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 25,762,000 | $22,928,000 | 0.34% |
| WOLVERINE ASSET MANAGEMENT LLC | 9,998,000 | $8,555,000 | 0.10% |
| PALISADE CAPITAL MANAGEMENT, LP | 1,331,000 | $1,138,000 | 0.04% |
| PUTNAM INVESTMENTS LLC | 2,876,000 | $2,459,000 | 0.01% |
| LAZARD ASSET MANAGEMENT LLC | 3,300,000 | $2,838,000 | 0.01% |
| AMERIPRISE FINANCIAL INC | 3,320,000 | $2,839,000 | 0.00% |
| UBS Group AG | 1,000 | $1,000 | 0.00% |
| Jefferies Group LLC | 10,000 | $8,000 | 0.00% |
| JPMORGAN CHASE & CO | 2,015,000 | $1,730,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 7,000 | $7,000 | 0.00% |